SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-18-000073
Accepted
2018-01-09 00:15:18
Documents
1
Effectiveness Date
2018-01-08
Registration Form
F-10

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 597
  Complete submission text file 9999999995-18-000073.txt   1680
Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1214
Type: EFFECT | Act: 33 | File No.: 333-222085 | Film No.: 18517775
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1